Login / Signup

Short-term outcomes of combined therapy with sirolimus and interferon-alpha 2b for advanced hepatic epithelioid hemangioendothelioma.

Xiaolei LiuRuiquan ZhouLiguo LiuShuang SiShiwei YangDongdong HanHaidong Tan
Published in: Therapeutic advances in medical oncology (2024)
Sirolimus and IFN-a 2b may have synergistic effects in the treatment of hepatic EHE. SI therapy is a safe and effective treatment for hepatic EHE patients with good ECOG performance status.
Keyphrases
  • dendritic cells
  • immune response
  • stem cells
  • drug delivery
  • bone marrow
  • cell therapy
  • combination therapy
  • replacement therapy
  • room temperature